Johnson & Johnson loses $10.7B after sweeping US tax changes
Johnson & Johnson posted a rare quarterly loss, a whopping $10.71 billion, due to a $13.6 billion charge related to last month's U.S. tax overhaul. While the loss was expected and the company's adjusted results beat Wall Street expectations, shares fell more than 4.1 percent, an unusually big swing for the health care giant.
from Biotech News
0 Comments